89 search results for screening
NCCN SOSF 2024 Thirteenth Annual Summary
has engaged with CMS and the FDA on issues such as Patient Navigation, SDOH screening, the Enhancing, to unfold, including additional engagements in screening/prevention, statutory passage of NCCN Guidelines® into law when appropriate, fertility preservation, access to hereditary cancer screening, of care from screening through survivorship. The conversation on screening resources was prominently featured on the panel. Dr. Krishna discussed the importance of lung cancer screening because the U.S
https://www.nccn.org/docs/default-source/oncology-policy-program/nccn-sosf-2024-thirteenth-annual-summary.pdf?sfvrsn=5346b0f5_1HERC Policy Handout
on the importance of the Human Papillomavirus (HPV) vaccine. SUPPORTING ACCESS TO SCREENING • Congress should allocate additional funding for CDC screening programs including the National Breast, ). Congress should also allocate funds for screening that prioritizes cancers where disparities, organizations to connect people with screening, early detection and treatment support. Congress should restore, and legislatures should expand their state Medicaid programs to increase access to screening, early
https://www.nccn.org/docs/default-source/oncology-policy-program/herc-policy-handout.pdf?sfvrsn=d10b4d1e_3All Breast Cancer Resources
Webinars for Patients Recorded Patient Webinars: Breast Cancer Screening (2024) Inflammatory, for patients. NCCN Guidelines for Patients Translations Breast Cancer Screening and Diagnosis Spanish
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/breast-cancer-resourcesNCCN_fact_sheet
as key cancer screening and prevention topics. These are available online free of charge for non, Use Criteria ( NCCN Imaging AUC ™) include recommendations pertaining to cancer screening
https://www.nccn.org/docs/default-source/news/nccn_fact_sheet.pdf?sfvrsn=e8bf8d9b_16The Alliance for Cancer Care Equity (ACCE)
, Screening and Early Detection; and Patient Navigation. To learn more about joining the ACCE
https://www.nccn.org/business-policy/policy-and-advocacy-program/the-alliance-for-cancer-care-equity-(acce)All Lung Cancer Resources
Spanish: Version 2024 Lung Cancer Screening Spanish: Version 2023 Click here to view the complete, , and Lung Cancer Screening. 3025 Chemical Road, Suite 100
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/lung-cancer-resourcesWorld Cancer Day
.” Laura Porter, MD Member of the NCCN Guidelines Panel for Colorectal Cancer Screening “Anybody
https://www.nccn.org/home/world-cancer-dayAdvocacy and Support Groups
focuses on cancer prevention and early detection via cancer screenings. Visit Screamin' for Screenings, to screening, education, treatment and psychosocial support programs serving millions of people, Association (GCCA) advocates for equitable access to quality colorectal cancer screenings, testing, cervical cancer prevention and outreach, new screening and treatment options, cervical cancer screening and follow-up programs, HPV, the limitations of the Pap smear AND its overwhelming success
https://www.nccn.org/patientresources/patient-resources/resources-for-patients-caregivers/advocacy-and-support-groupsGuidelines Panels
Cancer Screening and Diagnosis Panel, Colorectal Cancer Screening Panel, Lung Cancer Screening Panel
https://www.nccn.org/guidelines/guidelines-panels-and-disclosure/disclosure-panelsAbout the NCCN Guidelines for Patients
for the NCCN Guidelines for Patients: Breast Cancer Screening Digital Health Award Fall 2024
https://www.nccn.org/patientresources/patient-resources/about-the-nccn-patient-guidelinesOncology Policy Summits
the Care Continuum from Screening through SurvivorshipView Report | Digital Booklet of Patient Advocacy
https://www.nccn.org/business-policy/policy-and-advocacy-program/oncology-policy-summitsNCCN Compendia
that measure changes in genes or gene products and which are used for diagnosis, screening, monitoring, to cancer screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance
https://www.nccn.org/compendia-templates/compendia/nccn-compendiaNCCN December Advocacy Infographic
of effective cancer care and screening. • Easy access to reliable information and social support
https://www.nccn.org/docs/default-source/oncology-policy-program/nccn-december-advocacy-infographic.pdf?sfvrsn=51c5dda6_9Guidelines for Patients Translations
(Chinese) Guidelines for Patients® Colorectal Cancer Screening Version 2024 (Chinese, ® Colorectal Cancer Screening Version 2024 (Japanese) Korean Translation Guidelines, ® Breast Cancer Screening and Diagnosis Version 2022 (Spanish) Guidelines for Patients, Screening Version 2024 (Spanish) Guidelines for Patients® Cutaneous B-Cell Lymphomas Version, (Spanish) Guidelines for Patients® Lung Cancer Screening Version 2023 (Spanish
https://www.nccn.org/global/what-we-do/guidelines-for-patients-translationsNCCN Guidance on Inclusive Language
. For example: “Men and anyone with a prostate should discuss prostate cancer screening, appropriate opioid prescribing and screening for Opioid Use Disorder (OUD) for reproductive age female
https://www.nccn.org/docs/default-source/about/nccn-guidance-on-inclusive-language.pdf?sfvrsn=53c8c78f_2NCCN Guidelines for Patients with Permission Email
e a a n d Vomiting Cancer Screening Lung Cancer Screening Age-Related Adolescents and Yo u n g, of cancer care all over the world Expert recommendations for cancer screening, diagnosis, and treatment
https://www.nccn.org/docs/default-source/patient-resources/nccn-guidelines-for-patients-with-permission-email.pdf?sfvrsn=94769ebd_2Guidelines for Patients
Guidelines for Detection, Prevention, & Risk Reduction Breast Cancer Screening, Cancer Screening Version: 2024 Genetic, Version: 2025 Lung Cancer Screening
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patientsGuidelines for Patients
Breast Cancer Screening and Diagnosis Version: 2022, Cancer Screening Version: 2024 Cutaneous B, Screening Version: 2023 Mantle Cell
https://www.nccn.org/guidelines/patientsCurrent Opportunities
Tumor (Nephroblastoma) Breast Cancer Risk Reduction Breast Cancer Screening and Diagnosis Colorectal Cancer Screening Genetic/Familial High-Risk Assessment: Breast, Ovarian, Lung Cancer Screening Prostate Cancer Early Detection Adult Cancer Pain, Breast Cancer Breast Cancer - Metastatic Breast Cancer Breast Cancer Screening and Diagnosis, Screening Cutaneous B-Cell Lymphomas Cutaneous T-Cell Lymphomas Diffuse Large B-Cell Lymphomas
https://www.nccn.org/education-research/nccn-oncology-research-program/current-opportunitiesPermission to Cite or Use NCCN Content
Cancer Bone Cancer Breast Cancer Breast Cancer Risk Reduction Breast Cancer Screening, Leukemia/Small Lymphocytic Lymphoma Chronic Myeloid Leukemia Colon Cancer Colorectal Cancer Screening, Carcinoma Histiocytic Neoplasms Hodgkin Lymphoma Kaposi Sarcoma Kidney Cancer Lung Cancer Screening, Cancers Bladder Cancer Bone Cancer Breast Cancer Breast Cancer Risk Reduction Breast Cancer Screening, Screening Dermatofibrosarcoma Protuberans Distress Management Endometrial Carcinoma Esophageal
https://www.nccn.org/guidelines/permission-to-cite-or-use-nccn-content